July 2008 (liver carcinoma in March 2014, Various March cancers with 2015 and vascular November outside Aus and Sept May Sorafenib 4 Yes endothelial 11 None 2015 for funding no funding no funding NZ 2006 2007 growth thyroid restrictions factor as feature several times for renal cell and in Nov 2014 listed Aug GSIT Nov No 2013 outside outside No Sept Oct 2012, Sunitinib Sutent® Aus 2 No 0 (pNET), funding funding response 2006 2006 listed July 2008 restrictions restrictions mRCC (RCC), Nov 2010 July 2009 (GIST)
Sorafenib Aus and NZ 4 Yes Various cancers with vascular endothelial growth factor as feature 11 None Sept 2006 July 2008 (liver in March 2014, March 2015 and November 2015 for thyroid several times for renal cell carcinoma and in Nov 2014 outside funding restrictions May 2007 no funding no funding Sunitinib Sutent® Aus 2 No No response 0 No Sept 2006 Aug 2013 (pNET), July 2008 (RCC), July 2009 (GIST) outside funding restrictions Oct 2006 listed GSIT Nov 2012, listed mRCC Nov 2010 outside funding restrictions
1-s2.0-S0168851017303457-mmc1.docx